| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0.09 | 0.27 | 0.17 | 0.06 | 0.08 |
| Stock Adjustments | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0.09 | 0.27 | 0.17 | 0.06 | 0.08 |
| EXPENDITURE : | |||||
| Raw Materials | 0 | 0 | 0 | 0 | 0 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 0.01 | 0 | 0 | 0 | 0 |
| Other Manufacturing Expenses | 0.01 | 0.02 | 0 | 0 | 0.01 |
| Employee Cost | 0.08 | 0.13 | 0.08 | 0.04 | 0.03 |
| Selling and Administration Expenses | 0.16 | 0.13 | 0.08 | 0.09 | 0.07 |
| Miscellaneous Expenses | 0.18 | 3.71 | 0.01 | 0 | 0 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -0.33 | -3.71 | 0 | -0.07 | -0.03 |
| Interest and Financial Charges | 0 | 0.03 | 0 | 0 | 0 |
| Profit before Depreciation and Tax | -0.33 | -3.74 | 0 | -0.07 | -0.03 |
| Depreciation | 0.01 | 0.01 | 0 | 0 | 0 |
| Profit Before Tax | -0.34 | -3.75 | 0 | -0.07 | -0.03 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0.34 | -3.75 | 0 | -0.07 | -0.03 |
| Adjustment below Net Profit | 0.02 | -0.45 | 0.04 | 0 | 0 |
| P and L Balance brought forward | -4.29 | -0.09 | -0.13 | -0.06 | -0.03 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | -4.62 | -4.29 | -0.09 | -0.13 | -0.06 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 | 0 |
| Book Value | 2.93 | 3.43 | 9.86 | 9.8 | 9.9 |
| Extraordinary Items | -0.16 | -3.45 | 0.1 | 0 | 0 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 |
| Reserves and Surplus | -4.62 | -4.29 | -0.09 | -0.13 | -0.06 |
| Total Shareholders Funds | 1.91 | 2.24 | 6.44 | 6.4 | 6.47 |
| Secured Loans | 0.1 | 0 | 0.31 | 0 | 0 |
| Unsecured Loans | 0 | 0 | 0 | 0.27 | 0.14 |
| Total Debt | 0.1 | 0 | 0.31 | 0.27 | 0.14 |
| Total Liabilities | 2.01 | 2.24 | 6.75 | 6.67 | 6.61 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 2.56 | 2.56 | 5.95 | 5.26 | 0.01 |
| Less: Accum. Depreciation | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 |
| Net Block | 2.53 | 2.54 | 5.94 | 5.25 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 5.88 |
| Investments | 0.96 | 1.15 | 0.54 | 0.51 | 0.51 |
| Current Assets, Loans and Advances | |||||
| Inventories | 0 | 0 | 0 | 0 | 0 |
| Sundry Debtors | 0 | 0.01 | 0 | 0 | 0 |
| Cash and Bank Balance | 0.09 | 0.27 | 0.04 | 0.02 | 0.02 |
| Loans and Advances | 0.98 | 0.78 | 0.25 | 0.91 | 0.21 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 2.54 | 2.51 | 0.02 | 0.02 | 0.01 |
| Provisions | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Current Assets | -1.48 | -1.46 | 0.26 | 0.9 | 0.21 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 2.01 | 2.23 | 6.74 | 6.66 | 6.6 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
If I had made LUMPSUM investment of ₹ 1,00,000
in BACIL PHARMA LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
